deltatrials
Completed PHASE2 NCT00335712

Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus

Phase II Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus

Sponsor: Ono Pharma USA Inc

Conditions Type 2 Diabetes Mellitus
Interventions ONO-5129
Updated 5 times since 2017 Last updated: Jun 12, 2012 Started: Jun 30, 2006

This PHASE2 trial investigates Type 2 Diabetes Mellitus and is currently completed. Ono Pharma USA Inc leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jun 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ono Pharma USA Inc
Data source: Ono Pharmaceutical Co. Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations